Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 19,078 | 17,595 | 17,685 | 17,464 | 19,594 |
| Cost of Goods | 13,561 | 14,504 | 12,540 | 12,626 | 15,299 |
| Gross Profit | 5,517 | 3,091 | 5,146 | 4,838 | 4,295 |
| Operating Expenses | 1,103 | 1,183 | 1,352 | 1,182 | 1,051 |
| Operating Income | 4,414 | 1,908 | 3,794 | 3,656 | 3,245 |
| Other Income | 100 | 81 | 66 | 70 | 34 |
| Pre-tax Income | 4,515 | 1,989 | 3,860 | 3,727 | 3,278 |
| Income Tax | 1,176 | 516 | 1,001 | 663 | 885 |
| Net Income Continuous | 3,338 | 1,473 | 2,859 | 3,063 | 2,393 |
| Net Income | $3,338 | $1,473 | $2,859 | $3,063 | $2,393 |
| EPS Basic Total Ops | 0.17 | 0.07 | 0.14 | 0.16 | 0.12 |
| EPS Basic Continuous Ops | 0.17 | 0.07 | 0.14 | 0.16 | 0.12 |
| EPS Diluted Total Ops | 0.17 | 0.07 | 0.14 | 0.16 | 0.12 |
| EPS Diluted Continuous Ops | 0.17 | 0.07 | 0.14 | 0.16 | 0.12 |
| EBITDA(a) | $5,302 | $2,950 | $4,764 | $4,886 | $5,014 |